Introduction {#sec1-1359786810385490}
============

People with schizophrenia are known to die much earlier ([@bibr54-1359786810385490]) than expected. Up to 40% ([@bibr13-1359786810385490]) of this excess premature mortality can be attributed to suicide and unnatural deaths, with one authoritative review ([@bibr43-1359786810385490]) estimating a lifetime suicide risk of 4.9% for people with schizophrenia. Detection of those at risk is clinically important, but risk prediction is known to be imprecise ([@bibr23-1359786810385490]).

An earlier systematic review ([@bibr25-1359786810385490]) of risk factors for suicide in schizophrenia identified 29 high-quality data-containing studies which were analysed for individual risk factors. [@bibr25-1359786810385490] found, perhaps unsurprisingly, that many of the important risk factors for suicide in schizophrenia were similar to those in the general population, including mood disorder, recent loss, previous suicide attempts, and drug misuse. However, some other factors they identified as associated with high suicide risk in schizophrenia, such as fear of mental disintegration, agitation or restlessness, and poor adherence with treatment, are not immediately self-evident. Interestingly, [@bibr25-1359786810385490] also observed a reduced risk of suicide associated with the presence of hallucinations. Since that time, [@bibr61-1359786810385490] have confirmed, in a nationwide follow-up of individuals discharged from hospital after a first episode of schizophrenia, that not taking any regular antipsychotic medication was associated with a 12-fold increase in the relative risk of all-cause death and a worrying 37-fold increase in death by suicide.

Risk assessment and risk management remain core skills in clinical psychiatry. Since the 2005 review of Hawton et al., which examined data published up until June 2004, a large number of studies examining the rates and correlates of suicide in schizophrenia have been produced. For example, a recent non-systematic review by [@bibr16-1359786810385490] found many of the risk factors listed above to be important, as well as some disease-specific factors such as high suicide risk in the first year of illness and associations with a high premorbid function and high IQ, but also noted the low predictive specificity of these factors. We undertook a systematic review of all relevant studies published after June 2004 which provided new data on risk factors for suicide in schizophrenia to better inform clinical practice. We decided to only include studies likely to provide valid estimates of risk factors, namely randomized controlled trials, prospective and retrospective cohort studies, and case-control studies. As part of our systematic review we decided to rank the quality of the evidence, and hence assessed the quality of the included studies, according to standardized criteria.

Methods {#sec2-1359786810385490}
=======

Search strategy and study eligibility {#sec3-1359786810385490}
-------------------------------------

This systematic review included literature published between June 2004 and January 2010. An electronic search on the following databases were carried out -- EMBASE, PsychINFO and OVID Medline (R). The subject headings used included: Catatonic Schizophrenia or Paranoid Schizophrenia or Schizophrenia or Disorganized Schizophrenia or Childhood Schizophrenia or schizophrenia.mp., Psychotic Disorders or schizoaffective psychosis.mp., andSuicide.mp. or Suicide, andRisk factor.mp. or Risk Factors, andCohort Studies.mp. or Cohort Studies, Case Control Studies.mp. or Case-Control Studies, Cohort Analysis.mp. or Cohort Studies, Follow Up Studies.mp. or Follow-Up Studies

The results of the search were screened for suitability independently by both investigators. These studies were further screened for eligibility based on the inclusion criteria: Literature published in EnglishCase-control, cohort or follow-up studiesPatient diagnosis of schizophrenia (including all subtypes), psychosis and schizoaffective disorder

Data extraction {#sec4-1359786810385490}
---------------

The shortlisted studies were then analysed and the following data were extracted: Rate of suicideSocio-demographic information: age, gender, ethnicity, marital status, employment, education, social class, rural/urbanGenetic/biological information: genetics, family history of suicidal behaviour, biological markersIllness-related: age of onset, duration of disease, physical illness, affective disorder, thought disorder, depression, psychopathology, insightLife eventsPrevious suicide attempts/ideationSubstance misuse/abuse/dependence: alcohol, smoking, drugs

Quality of studies {#sec5-1359786810385490}
------------------

The studies included in this systematic review were assessed for quality. A score was given for study design: 4, randomized controlled trials; 3, prospective cohort/follow-up study; 2, retrospective cohort study; 1, case-control study. The studies were also assessed for the following characteristics: explicit aims, definition and size of population investigated, demographic details of subjects, explicit risk factors (if study looked at risk factors), validity and reliability of methods, response and drop-out rate specified, justification of response or drop-out rate, discussion of generalizability and discussion of limitations. Each of these criteria was allocated 1 point and the total score for each article was calculated. The six studies which provided data on over 100 subjects and had the highest quality scores were extracted and analysed in more detail, in order to ascertain recurrent findings or themes.

Results {#sec6-1359786810385490}
=======

Data extraction {#sec7-1359786810385490}
---------------

A total of 1281 articles were initially identified by the search strategy. Of the 1281 studies identified, 12 papers were not written in English and were therefore excluded from the study. Some 71 papers (out of 1269) were shortlisted for detailed analyses based on the abstracts; 20 of these papers were not included as they did not address the objectives of this study. A final total of 51 studies were identified as relevant to this study and were reviewed, as depicted in [Figure 1](#fig1-1359786810385490){ref-type="fig"}. Figure 1.Flow chart showing the article-identification process.

All 51 papers were further analysed for risk factors for suicide. The risk factors were grouped into six main categories -- Demographics, Illness-Related Factors, Insight, Suicide Attempt/Ideation, Life Events and Genetics.

The following studies provided new data on the rates of suicide in schizophrenia, which we have presented in [Table 1](#table1-1359786810385490){ref-type="table"}. Table 1*.*Rates of suicideStudyDetails of studyPopulationConclusion on suicide rates[@bibr44-1359786810385490]Retrospective observational study in China. Data for 1995--99 were extrapolated from data obtained from 1993Annual estimate of 4.25 million people with schizophrenia and 284,614 total suicides -- of which 28,737 suicides are by people with schizophrenia10.1% of all suicides had schizophrenia. Suicide rate in adults with schizophrenia was 6.8/1000 people/year. RR of suicide in those with schizophrenia vs. those without is 23.8.[@bibr56-1359786810385490]43 year prospective longitudinal Danish cohort study208 children in 'high-risk' group (based on mother\'s diagnosis of schizophrenia), 11 committed suicideSuicide was 14 times more likely in 'high-risk' subjects diagnosed with schizophrenia, compared with other mental disorders or no mental disorders[@bibr17-1359786810385490]Prospective cohort study. 5- and 10-year survival; absolute and relative mortality rates among first-admission patients with psychotic disorder235 patients with schizophrenia, 12 deaths due to all causes (four natural deaths, seven unnatural death, one unknown)1.7% of all patients with schizophrenia died by suicide[@bibr49-1359786810385490]10-year prospective follow-up study in rural China500 patients with schizophrenia; 21 died by suicideSuicide rate was 477/100000 person-years. SMR was 32.0. Risk of suicide during the follow-up period was 4.5%.[@bibr42-1359786810385490]Retrospective cohort study in general practices in UK from 1987--200246,136 patients with severe mental illness (40.2% with schizophrenia) included, matched with 300,426 controls48 (0.26%) patients with schizophrenia committed suicide; adjusted hazard ratio = 7.00[@bibr26-1359786810385490]Retrospective cohort study, North Wales, UK. Compared lifetime suicide rates in treated schizophrenia between cohorts from 1875--1924 and 1994--19981875--1924: 594 patients with schizophrenia, three suicides 1994--1998: 85 patients, four suicides1875--1924: 16/100000 patient-years, lifetime suicide rate of 0.46% 1994--1998: 752/100000 patient-years[@bibr41-1359786810385490]Case-control study using four Danish longitudinal registers from 1981--199718,744 individuals committed suicide in total, including 756 people with schizophreniaSuicide rates were found to decline from 1981--1997 by \>50%. Incidence rate ratio for suicide among patients with schizophrenia was about 20 times higher than the general population[@bibr14-1359786810385490]Follow-up study in Sweden from 1973--2006385 inpatients (153 men, 232 women) with schizophrenia spectrum psychosesRate of suicide during the follow-up period was 6.8%. Incidence rate ratio for suicide was 1.01[@bibr10-1359786810385490]Retrospective cohort study with Indian and American samples460 Indians and 424 AmericansMore attempted suicides in US (205/424 in US vs. 107/460 in India cohorts)[@bibr34-1359786810385490]10-year prospective follow-up study in France3470 patients with schizophrenia, 141 suicidesPrevalence of suicide (global SMR) was 16.2. Mortality due to suicide especially high during the first 4 years of follow-up[@bibr7-1359786810385490]10-year case-control study in Israel692 elderly patients with schizophrenia, 30 patients attempted suicideRate of suicide attempts was ∼5%, somewhat less than that reported for younger patients[@bibr30-1359786810385490]Retrospective cohort study using two population-based cohorts in DenmarkSchizophrenia: 17,660 first admissions and 3942 deceased. Schizoaffective: 4055 first admissions and 1261 deathsMortality rate ratio for suicide among male and female patients with schizophrenia was 34.51 and 58.81, respectively. Schizophrenia highest mortality rate ratio in the age groups 55--79 and 80+.[^1]

The new data on risk factors for suicide in schizophrenia were grouped into the six main themes noted above. Individual demographic characteristics identified as risk factors for suicide are depicted in [Table 2](#table2-1359786810385490){ref-type="table"}. Table 2.Patient demographicsCharacteristicNumber of studiesPositive associationNo associationConclusion on risk factorsAge107/10 identified young age as a predisposing risk factor for increased suicide. One study noted higher risk among patients \>50y/o, and another identified higher mean age of suicide among females, but not in malesYoung age not replicated in one studyYoung ageGender16Two studies identified females having a higher risk of suicide. Eleven studies found that males have a higher risk of suicideOne study did not replicate findings on male gender as a predisposing factor for suicide. Two studies found no difference in suicide between genderMalesEthnicity2One study showed that whites have higher suicide rate, another found that being born in Sweden predisposes to suicide--InconclusiveMarital status3Two studies found that being single predisposes to suicideOne study found that there was no difference in suicideSingleEmployment3Two studies found unemployment and inability to work, respectively, as increasing risk of suicide. One study identified minimal lost work potential amongst the suicide group--UnemploymentEducation6All six studies identified higher levels of education as a predisposing risk factor for suicide. One of the studies only found this amongst the Americans but not Indian subjects--Higher levels of educationSocial class4One study identified higher suicide rate in those from higher social class, and two studies identified homelessness and living alone, respectively, as positive risk factorsOne study found no difference in economic statusInconclusiveRural/urban1Rural \>urban by 3.18 times--Rural

Risk factors for later suicide that were identified from systematic review and were related to the individual's illness are shown in [Table 3](#table3-1359786810385490){ref-type="table"}. Table 3.Illness-related factorsCharacteristicNumber of studiesPositive associationNo associationConclusionAge of illness onset5Three studies identified later age of onset as a predisposing factor to increased suicide. One study found younger age of onset associated with suicideOne study found no differenceLater age of onsetDuration of illness6One study: ≥ 10 years, two studies: acute/shorter duration of illness, two studies: within first 3--5 years, one study: long illness with exacerbations--InconclusivePhysical illness2Both studies found positive correlation --Presence of physical illnessAffective disorder23Seven studies found positive correlation between affective disorders and increased suicide. Fifteen studies identified a positive relationship between the presence of depression and increased risk of suicideOnly one study found no difference in level of depression between attempters and non-attemptersHopelessness, negative self-thoughts. Presence of depressionPsychotic symptoms16Ten studies identified a positive correlation between positive psychotic symptoms and suicide in schizophrenia. Low levels of negative symptoms also showed a strong relationship with increased suicide in three studies. Also positive: higher level of baseline mental suffering (one study) and mental disintegration and agitation/restlessness (one study)One study found no relationship between suicide and lifetime occurrence of hallucinations or delusions. One study showed no difference in suicidality by mean number of negative symptomsIncreased positive symptoms, particularly auditory hallucinations and delusions, but lower levels of negative symptomsInsight5Four studies showed a positive correlation between suicide and insightOne study found no difference in suicide rates between groups with insight and withoutPresence of insightTreatment11Two studies identified increased suicide risk with current use of antidepressants and being treated by male psychiatrists. One study identified higher number of hospitalizations amongst those with who committed suicide. Protective factors include CBT, SGAs and deinstitutionalizationOne study found no difference in suicide rates between those who have been treated and those who have not. Another study identified no difference between groups treated with CBTp, supportive counselling or usual treatmentInconclusive. Studies suggest that second-generation antipsychotics are protective[^2]

Those familial or genetic characteristics studied, and elicited by our systematic review, in individuals with schizophrenia who later committed suicide are contained in [Table 4](#table4-1359786810385490){ref-type="table"}. Table 4.GeneticsCharacteristicNumber of studiesPositive associationNo associationConclusionFamily history4Three studies identified a positive correlation between family history of suicide (behaviour/attempt) and suicideOne study found no differencePositive family historyBiological markers1--No difference in CSF 5-HIAA levels and CSF HVA levels between suicide attempters and non-attemptersNo association between CSF 5-HIAA and HVA levels, and suicideGenetics2One study: COMT Del Allele confers susceptibility to suicide attempters. One study: difference in mean ratios, with the 'C' alleles showing lower cDNA levels in the suicide group; decreased total 5-HT2A receptor mRNA in suicide victims--Genes identified to be associated with suicide -- COMT Del Allele, "C" alleles and 5-HT2A receptor

The other three specific domains of risk factors associated with later suicide in people with schizophrenia are separated below:

### Suicide attempt/ideation {#sec8-1359786810385490}

Of the 51 studies, 10 evaluated history of suicide attempt/ideation as a risk factor for suicide in patients with schizophrenia. All 10 studies identified a positive correlation between suicide attempt/ideation and suicide.

### Substance abuse {#sec9-1359786810385490}

Of the seven studies that looked into substance misuse, four studies identified alcohol as a predisposing factor to increased suicides among patients with schizophrenia, while three studies identified substance abuse and one study identified smoking only. Only one study found no difference in current substance abuse in those who committed suicide.

### Life events {#sec10-1359786810385490}

Only two studies looked at life events as a risk factor for suicide. One of the studies looked at childhood trauma and found that patients who committed suicide had higher scores on the Childhood Trauma Questionnaire. Another study found that those with schizophrenia had a higher number of life events compared with a normal control group, but people with schizophrenia who were suicidal had fewer incidences of life events than those who were non-suicidal.

Our systematic quality analysis of all available included studies, using the scoring criteria noted above, yielded the following results ([Table 5](#table5-1359786810385490){ref-type="table"}): Table 5.Quality analysis of all included original studiesStudyStudy designPercentage of maximum quality score (%)[@bibr18-1359786810385490]Prospective Cohort Study92[@bibr22-1359786810385490]Randomized Controlled Trial92[@bibr49-1359786810385490]Follow-Up/Cohort Study92[@bibr47-1359786810385490]Prospective Cohort Study92[@bibr39-1359786810385490]Randomized Controlled Trial92[@bibr48-1359786810385490]Prospective Cohort Study92[@bibr55-1359786810385490]Prospective Case-Control Study85[@bibr2-1359786810385490]Retrospective Cohort Study85[@bibr29-1359786810385490]Follow-up Cohort Study85[@bibr45-1359786810385490]Retrospective Cohort Study85[@bibr35-1359786810385490]Prospective Cohort Study85[@bibr10-1359786810385490]Retrospective Cohort Study85[@bibr34-1359786810385490]Prospective Follow-up Study85[@bibr36-1359786810385490]Retrospective Cohort Study85[@bibr11-1359786810385490]Retrospective Cohort Study85[@bibr8-1359786810385490]Randomized Controlled Trial85[@bibr56-1359786810385490]Prospective Cohort Study77[@bibr14-1359786810385490]Follow-Up/Cohort Study77[@bibr60-1359786810385490]Follow-Up/Cohort Study77[@bibr26-1359786810385490]Retrospective Cohort Study77[@bibr9-1359786810385490]Randomized Controlled Trial77[@bibr30-1359786810385490]Retrospective Cohort Study77[@bibr28-1359786810385490]Retrospective Cohort Study77[@bibr63-1359786810385490]Retrospective Cohort Study77[@bibr7-1359786810385490]Retrospective Case-Control Study77[@bibr57-1359786810385490]Retrospective Case-Control Study77[@bibr52-1359786810385490]Retrospective Case-Control Study77[@bibr15-1359786810385490]Prospective Cohort Study77[@bibr46-1359786810385490]Prospective Cohort Study77[@bibr7-1359786810385490]Retrospective Case-Control Study77[@bibr59-1359786810385490]Prospective Randomized Controlled Trial77[@bibr58-1359786810385490]Retrospective Cohort Study77[@bibr4-1359786810385490]Retrospective Cohort Study77[@bibr3-1359786810385490]Prospective Cohort Study77[@bibr51-1359786810385490]Follow-up Study77[@bibr40-1359786810385490]Case-Control Study77[@bibr50-1359786810385490]Retrospective Cohort Study77[@bibr32-1359786810385490]Retrospective Cohort Study69Barak et al. (2008)Case-Control Study69[@bibr31-1359786810385490]Case-Control Study69[@bibr37-1359786810385490]Case-Control Study69[@bibr42-1359786810385490]Retrospective Cohort Study69[@bibr24-1359786810385490]Retrospective Cohort Study69[@bibr53-1359786810385490]Retrospective Case-Control Study69[@bibr33-1359786810385490]Case-Control Study69[@bibr19-1359786810385490]Case-Control Study62[@bibr12-1359786810385490]Follow-Up/Cohort Study62[@bibr20-1359786810385490]Case-Control Study62[@bibr27-1359786810385490]Retrospective Cohort Study62[@bibr44-1359786810385490]Retrospective Cohort Study62[@bibr21-1359786810385490]Case-Control Study46

The top six articles (percentage of maximum quality score = 92%) were extracted for more detailed analysis. [Table 6](#table6-1359786810385490){ref-type="table"} summarizes the details on methods, risk factors investigated and conclusions of each of these six studies. Table 6.Summary of the highest-quality studies of risk factors for suicide in schizophreniaStudyTitle of paperDetails of participantsConclusions re increased suicide risk[@bibr18-1359786810385490]Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia101 participants, suicide attempts was used as a measurementInsight is associated with increased risk of suicide attempts. Insight is also associated with depression[@bibr22-1359786810385490]Understanding suicidal ideation in psychosis: findings from the Psychological Prevention of Relapse in Psychosis (PRP) trial290 patientsYounger age and male gender not replicated Whites Anxiety, negative beliefs and depression Auditory hallucinations Daily alcohol consumption[@bibr49-1359786810385490]Mortality in people with schizophrenia in rural China: 10-year cohort study500 patients\>50 y/o, male gender and inability to work associated with increased riskAge of onset \> 45 y/o, duration of disease ≥ 10 years, physical illnessReduced risk with treatment[@bibr47-1359786810385490]Differences in mortality and suicidal behaviour between treated and never-treated people with schizophrenia in rural China500 patients, 132 never received antipsychotic and 368 reported having received antipsychotic treatmentSuicide rates were not significantly different between treated and non-treated schizophrenic patients. Overall mortality rates in patients are high when compared with general population (\>6.5 times)[@bibr39-1359786810385490]Suicidal ideation and attempts among middle-aged and older patients with schizophrenia spectrum and concurrent subsyndromal depression.132 patientsMale gender Hopelessness, depression, higher PANSS general psychopathology subscale scoresHistory of suicidal ideation[@bibr48-1359786810385490]Mortality of geriatric and younger patients with schizophrenia in the community500 patientsPatients from the younger age group had higher suicide rates[^3]

Discussion {#sec11-1359786810385490}
==========

This systematic review included findings from 51 articles published from June 2004 to January 2010. The main findings from this review are as follows:

Suicide rate in schizophrenia {#sec12-1359786810385490}
-----------------------------

Studies so far have not come to an agreement on suicide rates amongst patients with schizophrenia. The most widely cited lifetime suicide rate is 10%, as estimated by a review by [@bibr38-1359786810385490]. However, a recent study by [@bibr43-1359786810385490] has challenged this and has proposed that the lifetime suicide risk in schizophrenia is approximately 4.9%. The current review analysed contemporary data on suicide rates amongst patients with schizophrenia, and we conclude that an accurate estimated suicide rate is 579/100,000 person-years (477--680/100,000 person-years). However, two other studies that investigated the proportion of people who died due to suicide who also had schizophrenia reported a rate of 10.1% ([@bibr44-1359786810385490]) and 22.3% ([@bibr42-1359786810385490]), but proportionate mortality should not be confused with lifetime risk.

It is perhaps not surprising that different studies, using different populations and methodologies, return varying estimates of the suicide rate in schizophrenia. Also, the 'true' suicide rate will fluctuate over time, depending on numerous complex variables including the period over which the studies were carried out. In addition, many suicides may be misclassified as 'unnatural' or 'undetermined' deaths. However, most studies seem to indicate that the earlier consensus figure of 10% lifetime risk is an overestimate (perhaps due to confusion with proportionate mortality), with a lifetime risk of around 5% being more representative, and compatible with various studies we analysed ([@bibr5-1359786810385490]; [@bibr14-1359786810385490]; [@bibr50-1359786810385490], [@bibr51-1359786810385490]; [@bibr34-1359786810385490]). This 5% figure remains significantly higher than the general population risk of suicide.

We decided it would be clinically relevant and helpful to classify the data on risk factors for suicide in schizophrenia, according to the strength of the findings in the data reviewed. Thus we produced [Table 7](#table7-1359786810385490){ref-type="table"}, which summarizes those risk factors which have a strong association, and those with a weaker (or negative) association for later suicide. Table 7.Summary of risk factors associated with suicide in schizophreniaRisk factorStrong association with suicideWeak association with suicideDemographic factorsYoung, male, unemployment, with higher levels of educationSingle (not married), ruralIllness-related factorsPresence of depression, hopelessness, negative self-thoughts, anxiety, insomnia, self-devaluation, low self-esteem, guilty thoughts and PTSDTreatment (in particular, second-generation antipsychotic) may be a protective factor against suicideIncreased positive symptoms, in particular auditory hallucinations and delusions; low negative symptoms; higher level of mental suffering at baseline; mental disintegration and agitation/motor restlessnessLater age of onset The impact of duration of disease on suicide risk is inconclusivePresence of insightPresence of physical illnessesGeneticsPositive family historyPrevious suicide attempt/ideationStrong correlation with history of suicide attempt/ideationSubstance abuseAlcohol and drug abuseSmokingLife eventsPotentially increased risk with history of increased childhood trauma[^4]

What have we learnt since 2005? {#sec13-1359786810385490}
-------------------------------

This systematic review has replicated some of the key findings found in [@bibr25-1359786810385490], including identifying a strong association with later suicide in schizophrenia and earlier depression, history of suicide attempts, and drug misuse. Depression is one of the major risk factors for suicide among individuals with schizophrenia. A randomized controlled trial (OPUS Trial) ([@bibr9-1359786810385490]) investigated suicidal thoughts and plans, depressive symptoms and drug misuse in predicting suicidal attempts at 1- and 2-year follow-up. This trial has shown that suicidal thoughts and plans, previous suicide attempts and depressive symptoms are among the strongest predictors of suicidality in patients presenting with first-episode psychosis. One of our top-scoring articles ([@bibr22-1359786810385490]) used the Beck Depression Inventory as a measure of the severity of depression and its association with the risk of committing suicide. This study has shown that the likelihood of patients with scores equal or greater than 2 on Suicide Item (9) committing suicide increases by seven-fold.

A history of prior suicide attempts elevates risk of completed suicide threefold according to both [@bibr52-1359786810385490] and [@bibr57-1359786810385490], who found that individuals who were admitted for an attempted suicide had the highest risk (of all variables studied) of committing suicide (Odds Ratio (OR) = 8.10).

In addition to drug misuse, we also identified alcohol misuse as a key risk factor for suicide. The WHO Mental Health Surveys ([@bibr62-1359786810385490]) aimed to identify mental disorders associated with suicidal behaviour and have shown that alcohol (OR = 2.6) and drug (OR = 2.0) abuse or dependency are strong predictive factors for suicide. However, one of the studies included in this review ([@bibr36-1359786810385490]) has shown that substance abuse does not increase risk of suicide amongst patients with schizophrenia (alcohol abuse and lifetime suicide risk OR = 0.29, drug abuse and lifetime suicide risk OR = 0.94), although this study used data from interviews with family members of the deceased patients, which may not be the most accurate source of information.

[@bibr25-1359786810385490] found that poor adherence to treatment is associated with increased risk of suicide (OR = 3.75). Some of the studies included in this review have shown that individuals who underwent treatment had a smaller risk of committing suicide ([@bibr5-1359786810385490]; [@bibr46-1359786810385490]; [@bibr51-1359786810385490]), but one particular study ([@bibr47-1359786810385490]) found no significant difference between suicide rates between the treated and non-treated group, although [@bibr47-1359786810385490] found that the non-treated group had more severe symptoms.

An interesting finding in this study is the association between the presence of positive symptoms, in particular auditory hallucinations and delusions, and an increased risk of suicide among patients with schizophrenia. This is in contrast with the findings reported by [@bibr25-1359786810385490]. This difference may be due to the heterogeneity of the data in [@bibr25-1359786810385490] which resulted in a relatively weak association between hallucinations and reduced risk of suicide. While our study has identified a positive association, further studies are required to confirm this.

Conventional wisdom suggests that increased risk of suicide in schizophrenia is associated with young age. However, some of the studies ([@bibr22-1359786810385490]; [@bibr29-1359786810385490]; [@bibr49-1359786810385490]; [@bibr52-1359786810385490]) included in this review have challenged this association, with both [@bibr52-1359786810385490] and [@bibr29-1359786810385490] finding that a later age of illness onset is associated with an increased risk of suicide. [@bibr49-1359786810385490] identified that age (\>50 years old, hazard ratio = 4.8) and age at illness onset (\>45 years old, hazard ratio = 9.2) are independent predictors of mortality in the population studied, but this study did not define the causes of death or investigate specific predictors of suicide. The difference in conclusions about age as a risk factor for suicide in patients with schizophrenia may be a result of the design of the study, with shorter-term studies having a tendency of identifying younger patients as a higher risk group. Further studies are needed to identify if older age and later age of onset are indeed strong predictors of suicide, and such studies should take into account the severity of psychotic symptoms, chronicity of illness, and other co-morbidities including affective disorders. Until then, the weight of evidence supports a younger age as a risk factor.

Some of the risk factors identified in this systematic review may be similar or may oppose those observed in the general population, as [@bibr1-1359786810385490] has pointed out. However, for the purposes of this study, the risk factors identified are in relation to patients with schizophrenia and are not compared with risk factors in the general population. This systematic review looked at studies that identified either suicide or suicide ideation as an outcome. This may potentially affect our findings, although a history of suicide attempt or ideation has a strong positive correlation with completed suicide among patients with schizophrenia. Therefore, we feel that inclusion of studies with suicide ideation or attempt as an outcome in this study is justified.

Limitations {#sec14-1359786810385490}
-----------

We did not attempt to perform a meta-analysis, which would allow a quantitative analysis of predictors of suicide for schizophrenia. However, differing study designs of studies included in this systematic review mean that not all data are amenable to meta-analysis. We only reviewed papers that were published in English.

Conclusions {#sec15-1359786810385490}
===========

Since an earlier systematic review conducted by [@bibr25-1359786810385490], there have been numerous studies published concerning suicide in schizophrenia. We included 51 new data-containing studies in this critical systematic review, and found that the factors with the strongest association with later suicide (in schizophrenia) included being young and male, with a higher level of education. Illness-related factors were also important predictors, namely depressive symptoms, a history of suicide attempts, active hallucinations (contrary to [@bibr25-1359786810385490]) and delusions, the presence of insight, and comorbid chronic physical illness. Lastly, a family history of suicide and co-existing alcohol and drug misuse were also factors with a strong association with later suicide. Adequate treatment for schizophrenia and related comorbid problems was the only protective factor identified.

Prevention of suicide in schizophrenia would thus rely on identifying those individuals with the risk factors noted above, and actively treating any comorbid depressive illness and positive psychotic symptoms, as well as addressing any co-existent substance misuse. However, suicide prediction in those with schizophrenia is complex, and efforts at prevention should also focus on optimizing adherence to medication, and possible earlier use of clozapine, as the only antipsychotic medication with demonstrated efficacy (and a licence in the USA) for the management of suicidality in schizophrenia.

Funding {#sec16-1359786810385490}
=======
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[^1]: RR, relative risk; SMR, standardised mortality ratio.

[^2]: CBT, cognitive behavioural therapy; SGA, second generation antipsychotic.

[^3]: PANSS, positive and negative syndrome scale

[^4]: PTSD, post-traumatic stress disorder
